IL1B and mastitis: In an A. viridans-induced mouse mastitis model, a single 25-μg dose of AVPL significantly reduced bacterial loads in the mammary glands (~2-log10), alleviated mastitis-related pathological symptoms, and decreased inflammatory cytokine levels (TNF-α, IL-1β, and IL-6) in mammary tissues [68].